GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 41 filers reported holding GALERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,552,000 | +4.1% | 2,100,000 | -14.6% | 0.51% | +21.9% |
Q1 2023 | $6,295,094 | +71.8% | 2,459,021 | 0.0% | 0.42% | +81.2% |
Q4 2022 | $3,663,941 | -14.4% | 2,459,021 | 0.0% | 0.23% | +12.3% |
Q3 2022 | $4,279,000 | +33.8% | 2,459,021 | 0.0% | 0.20% | +29.9% |
Q2 2022 | $3,197,000 | -45.4% | 2,459,021 | 0.0% | 0.16% | -49.2% |
Q1 2022 | $5,852,000 | -48.2% | 2,459,021 | 0.0% | 0.31% | -42.1% |
Q4 2021 | $11,287,000 | -43.3% | 2,459,021 | 0.0% | 0.53% | -48.2% |
Q3 2021 | $19,918,000 | -17.6% | 2,459,021 | 0.0% | 1.03% | -3.9% |
Q2 2021 | $24,172,000 | +11.4% | 2,459,021 | 0.0% | 1.07% | +19.6% |
Q1 2021 | $21,689,000 | -28.4% | 2,459,021 | -16.9% | 0.90% | -31.0% |
Q4 2020 | $30,271,000 | -1.8% | 2,959,021 | -13.2% | 1.30% | -15.2% |
Q3 2020 | $30,818,000 | +26.6% | 3,409,021 | 0.0% | 1.53% | -2.6% |
Q2 2020 | $24,340,000 | -24.8% | 3,409,021 | 0.0% | 1.57% | -27.3% |
Q1 2020 | $32,386,000 | -27.8% | 3,409,021 | 0.0% | 2.16% | -25.2% |
Q4 2019 | $44,863,000 | – | 3,409,021 | – | 2.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 3,083,712 | $40,582,000 | 2.92% |
Novo Holdings A/S | 3,409,021 | $44,863,000 | 2.89% |
NEA Management Company, LLC | 4,362,986 | $57,417,000 | 2.72% |
SPHERA FUNDS MANAGEMENT LTD. | 471,439 | $6,204,000 | 0.51% |
RA Capital Management | 1,054,178 | $13,873,000 | 0.42% |
Rock Springs Capital Management LP | 500,000 | $6,580,000 | 0.21% |
Tekla Capital Management LLC | 416,666 | $5,483,000 | 0.21% |
Blackstone Inc. | 1,678,984 | $22,095,000 | 0.14% |
Perceptive Advisors | 325,000 | $4,277,000 | 0.08% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,300,000 | $17,108,000 | 0.04% |